Reportlinker Adds Japanese Market for Interventional Cardiology 2010
(No summary provided, please click and read the full article.)
|
|||
|
|
|
Acquisition of ATS Medical Will Increase Medtronic's Share in the ...With an effective merger, the combined share of Medtronic and ATS Medical could climb higher than the 15% seen in 2009; however, the biggest revenue gains for Medtronic will come when percutaneous heart valves are launched in the US. All three recent acquisitions were developing devices for transcatheter aortic valve implantation, securing Medtronic's product offering in this space in front of some heavy competition from Edwards Lifesciences, who is expected to be the ... Mo.Ma cerebral protection device(No summary provided, please click and read the full article.) Transcutaneous aortic valve implantation using the axillary ...OBJECTIVE: Retrograde transfemoral artery catheterization is the most common way of implanting a percutaneous aortic valve. But in some cases, this access cannot be used and the subclavian artery access may represent an ... This article describes prosthetic aortic valve implantation using the subclavian arterial approach and reports the findings. METHODS: The valve prosthesis is a self-expandable, nitinol-based device (CoreValve; Medtronic Inc. Minneapolis, Minn). ... Acquisition of ATS Medical Will Increase Medtronic's Share in the ...(No summary provided, please click and read the full article.) Transcatheter valve-in-valveAs reported by heartwire, both the CoreValve (Medtronic, Minneapolis, MN) and Edwards's Sapien transcatheter aortic devices are already marketed and widely used in Europe, while American physicians are looking forward to FDA approval. ... Most of the aortic-valve procedures used the transapical approach through the apex of the left ventricle. The pulmonary procedures used a percutaneous transvenous access, and the lone tricuspid implant was through a thoracotomy with ... Risk and Fate of Cerebral Embolism After Transfemoral Aortic Valve ...(No summary provided, please click and read the full article.) "The Gray Sheet" :: MEDICAL DEVICES, DIAGNOSTICS AND INSTRUMENTATIONMedtronic's CoreValve program. International post-market CoreValve Advance study, which will assess up to 1000 patients with severe aortic stenosis implanted with the transcatheter aortic valve system, is underway, ... The primary endpoint of CoreValve Advance is major adverse cardiac and cerebrovascular events 30 days post-procedure, defined as a composite of all-cause mortality, myocardial infarction, emergent cardiac surgery or percutaneous re-intervention and stroke. ... Medtronic Starts International Study Of CoreValve(R) Transcatheter ...(No summary provided, please click and read the full article.) Medtronic Starts International Study of CoreValve® Transcatheter ...Most of the trial sites will be in Europe, where the CoreValve system is used in approximately 75 percent of transcatheter aortic valve replacements involving percutaneous femoral access. Study patients will be followed for at least ... Most Anatomy Suitable for Contemporary TAVI Approaches - TCTMD
Onset Medical Receives US FDA Marketing Clearance For Additional - Medical Design Online (press release)
|
